PatientsLikeMe ™

all
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Eldepryl, Emsam, Otrasel, Zelapar

What is Selegiline? Selegiline is a MAO-B inhibitor which slows the breakdown of l-dopa. Used in combination with l-dopa containing drugs such as Sinemet it can improve their efficacy. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

144 patients in the community are taking or have taken Selegiline.

Dosages

Based on the patients currently taking Selegiline.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 mg none 0.1 mg day 0.5 mg day 1.25 mg day 1.5 mg day 1.5 day 2.25 mg day 2.5 mg day 3 mg day 5 mg day 5 mg none 6 mg day 10 mg day 12 mg day 15 mg day 20 mg day 40 mg day 125 mg day
  9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 14 Number of Patients: 14 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 11 Number of Patients: 11 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 36 Number of Patients: 36 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Selegiline or how long patients were taking Selegiline before stopping.

Currently taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
5
8
14
17
25

Stopped taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
10
2
6
3
6
15
Why Patients Stopped Taking Selegiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 13 30% Did not seem to work: 30%
Side effects too severe 12 27% Side effects too severe: 27%
Doctor's advice 11 25% Doctor's advice: 25%
Other 8 18% Other: 18%
Personal research 6 14% Personal research: 14%
Expense 3 7% Expense: 7%
Not indicated 2 5% Not indicated: 5%
Course of treatment ended 1 2% Course of treatment ended: 2%

Patient Reported Evaluations

Results from 11 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 38% 3
Moderate 25% 2
Slight 25% 2
Can't tell 13% 1

Treat Parkinson's

Side-effects (as an overall problem)

Severe 18% 2
Moderate 9% 1
Mild 9% 1
None 64% 7

Top reported side-effects include: trouble falling asleep, tiredness, Psychosis

Summary results are based on 11 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 11)

  • EfficacyCan't tell
  • Side-effectsNone
  • Treat Parkinson's

  • EfficacyModerate
  • Side-effectsNone
  • Depression
Advice/Tips
stick with it

See all evaluation results for Selegiline



Back to top